Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trial-Reference-Cited by-同舟云学术

Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trial

Published:2024-09 Issue: Volume: Page:
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Isa Flonza,Gonzalez Ortiz Ana M,Meyer Jonathan,Hamilton Jennifer D,Olenchock Benjamin A,Brackin Taylor,Ganguly Samit,Forleo-Neto Eduardo,Faria Lori,Heirman Ingeborg,Marovich Mary,Hutter Julia,Polakowski Laura,Irvin Susan C,Thakur Mazhar,Hooper Andrea T,Baum Alina,Petro Christopher D,Fakih Faisal A,McElrath M Juliana,De Rosa Stephen C,Cohen Kristen W,Williams LaTonya D,Hellman Caleb A,Odeh Ahmad J,Patel Aloki H,Tomaras Georgia D,Geba Gregory P,Kyratsous Christos A,Musser Bret,Yancopoulos George D,Herman Gary A,Turner Kenneth C,Kim Yunji,Konis George,Rosenthal Mark J,Trbovic Caryn F,Kowal Bari,DiCioccio A Thomas,Dakin Paula

Funder

Regeneron Pharmaceuticals Inc

Publisher

Elsevier BV

Reference31 articles.

1. REGEN-COV antibody combination and outcomes in outpatients with COVID-19;Weinreich;N Engl J Med,2021

2. Subcutaneous REGEN-COV antibody combination to prevent COVID-19;O'Brien;N Engl J Med,2021

3. Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection;Greaney;Sci Transl Med,2021

4. Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serum;Bates;Nat Commun,2021

5. Oral nirmatrelvir for high-risk, nonhospitalized adults with COVID-19;Hammond;N Engl J Med,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Weighing up monoclonals and vaccination against COVID-19;The Lancet Infectious Diseases;2024-09